- Home
- OCC vs CNTX Comparison
OCC vs CNTX Comparison
Compare OCC & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- CNTX
- Stock Information
- Founded
- OCC 1983
- CNTX 2015
- Country
- OCC United States
- CNTX United States
- Employees
- OCC N/A
- CNTX N/A
- Industry
- OCC Telecommunications Equipment
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- OCC Industrials
- CNTX Health Care
- Exchange
- OCC Nasdaq
- CNTX Nasdaq
- Market Cap
- OCC 76.4M
- CNTX 75.6M
- IPO Year
- OCC 1996
- CNTX 2021
- Fundamental
- Price
- OCC $9.17
- CNTX $1.13
- Analyst Decision
- OCC
- CNTX Strong Buy
- Analyst Count
- OCC 0
- CNTX 7
- Target Price
- OCC N/A
- CNTX $5.20
- AVG Volume (30 Days)
- OCC 116.7K
- CNTX 260.4K
- Earning Date
- OCC 09-11-2025
- CNTX 11-05-2025
- Dividend Yield
- OCC N/A
- CNTX N/A
- EPS Growth
- OCC N/A
- CNTX N/A
- EPS
- OCC N/A
- CNTX N/A
- Revenue
- OCC $72,694,849.00
- CNTX N/A
- Revenue This Year
- OCC N/A
- CNTX N/A
- Revenue Next Year
- OCC N/A
- CNTX N/A
- P/E Ratio
- OCC N/A
- CNTX N/A
- Revenue Growth
- OCC 12.67
- CNTX N/A
- 52 Week Low
- OCC $2.02
- CNTX $0.49
- 52 Week High
- OCC $10.22
- CNTX $2.59
- Technical
- Relative Strength Index (RSI)
- OCC 59.33
- CNTX 69.12
- Support Level
- OCC $8.50
- CNTX $0.98
- Resistance Level
- OCC $10.22
- CNTX $1.29
- Average True Range (ATR)
- OCC 0.84
- CNTX 0.09
- MACD
- OCC -0.04
- CNTX 0.02
- Stochastic Oscillator
- OCC 53.42
- CNTX 65.91
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.